Literature DB >> 17660227

Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results.

S Tanno1, Y Nakano, T Nishikawa, K Nakamura, J Sasajima, M Minoguchi, Y Mizukami, N Yanagawa, T Fujii, T Obara, T Okumura, Y Kohgo.   

Abstract

BACKGROUND AND AIMS: Although branch duct intraductal papillary-mucinous neoplasms (IPMNs) of the pancreas without mural nodules are frequently observed in asymptomatic subjects, the natural history of these lesions has never been studied. The aim of this study was to elucidate the natural history of branch duct IPMNs without mural nodules.
METHODS: Eighty-two patients who had no apparent mural nodules on initial examination were selected for follow-up. All subjects underwent examinations by imaging modalities including endoscopic retrograde pancreatography, and were followed-up by regular examinations once or twice a year. Serial changes of the maximum cystic diameter and the appearance of mural nodules were studied during the observation periods ranging from 14 to 148 months (median, 61 months).
RESULTS: Nine (11.0%) of 82 patients exhibited obvious progression of cystic dilatation (median, 59 months). Of these nine patients with cystic enlargement, six continued with regular follow-up examinations. Three cases underwent surgical resection, and were pathologically diagnosed as adenoma in two and borderline in one. Four patients (4.9%) showed newly developed mural nodules in dilated branch ducts (median, 105 months). Histological analysis revealed three cases classified as adenoma and one as carcinoma in situ. None of the remaining 69 patients (84.1%) showed any changes in dilated branch ducts (median, 57 months).
CONCLUSIONS: Most branch duct IPMNs without mural nodules remained unchanged during long-term follow-up. Although follow-up with careful examination is required to detect newly developed mural nodules in dilated branch ducts, branch duct IPMNs without mural nodules can be followed-up without surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17660227     DOI: 10.1136/gut.2007.129684

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  64 in total

Review 1.  Intraductal papillary mucinous neoplasia (IPMN) of the pancreas: its diagnosis, treatment, and prognosis.

Authors:  Robert Grützmann; Stefan Post; Hans Detlev Saeger; Marco Niedergethmann
Journal:  Dtsch Arztebl Int       Date:  2011-11-18       Impact factor: 5.594

2.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

Review 3.  IPMN: surgical treatment.

Authors:  Reto M Käppeli; Sascha A Müller; Bianka Hummel; Christina Kruse; Philip Müller; Jürgen Fornaro; Alexander Wilhelm; Marcel Zadnikar; Bruno M Schmied; Ignazio Tarantino
Journal:  Langenbecks Arch Surg       Date:  2013-09-03       Impact factor: 3.445

Review 4.  [Importance of endoscopy and endosonography for chronic pancreatitis and benign pancreas tumors].

Authors:  M Fuchs; W Schepp
Journal:  Radiologe       Date:  2008-08       Impact factor: 0.635

Review 5.  [Cystic lesions of the pancreas].

Authors:  B Buerke; C Schülke
Journal:  Radiologe       Date:  2015-02       Impact factor: 0.635

Review 6.  Endoscopic Management of Pancreatic Cysts.

Authors:  Michael J Bartel; Massimo Raimondo
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

7.  Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis.

Authors:  Edward S Huang; G Scott Gazelle; Chin Hur
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

8.  Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.

Authors:  Stefano Crippa; Carlos Fernández-Del Castillo; Roberto Salvia; Dianne Finkelstein; Claudio Bassi; Ismael Domínguez; Alona Muzikansky; Sarah P Thayer; Massimo Falconi; Mari Mino-Kenudson; Paola Capelli; Gregory Y Lauwers; Stefano Partelli; Paolo Pederzoli; Andrew L Warshaw
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-14       Impact factor: 11.382

Review 9.  Management of mucin-producing cystic neoplasms of the pancreas.

Authors:  Stefan Fritz; Andrew L Warshaw; Sarah P Thayer
Journal:  Oncologist       Date:  2009-02-11

10.  Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications.

Authors:  Gian Luca Baiocchi; Nazario Portolani; Guido Missale; Carla Baronchelli; Federico Gheza; Massimiliano Cantù; Luigi Grazioli; Stefano M Giulini
Journal:  World J Surg Oncol       Date:  2010-04-07       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.